Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next? Unlock AI-picked Stocks
Close

Novozymes A/S B (NSISb)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
385.4 -2.5    -0.64%
14:18:35 - Real-time Data. Currency in DKK ( Disclaimer )
  • Volume: 118,764
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 384.9 - 390.8
Type:  Equity
Market:  Denmark
ISIN:  DK0060336014 
S/N:  414555046
Novozymes B 385.4 -2.5 -0.64%

Novozymes A/S B Latest Cash Flow Statement

 
Use the Novozymes A/S B cash flow statement to assess the changes in NSISb's cash and cash equivalents.

The NSISb cash flow chart shows Net Income, Cash from Operating, Financing and Investing Activities, as well as Novozymes B free cash flow, yield and ending cash balance.
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 698 936 606 784
Cash From Operating Activities 1122 1586 1130 314
Depreciation/Depletion 65 332 335 357
Amortization 198 - - -
Deferred Taxes 92 - - -
Non-Cash Items -360 109 113 49
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 490 65 75 160
Cash Interest Paid 84 18 32 23
Changes in Working Capital 419 209 76 -876
Cash From Investing Activities -603 -486 -705 -339
Capital Expenditures -488 -437 -517 -415
Other Investing Cash Flow Items, Total -115 -49 -188 76
Cash From Financing Activities -555 -977 -456 99
Financing Cash Flow Items -30 - -297 297
Total Cash Dividends Paid -1163 - -1 -1662
Issuance (Retirement) of Stock, Net 79 8 9 71
Issuance (Retirement) of Debt, Net 559 -985 -167 1393
Foreign Exchange Effects - 2 -17 -36
Net Change in Cash -59 127 -52 59
Beginning Cash Balance 1175 1048 1100 1041
Ending Cash Balance 1116 1175 1048 1100
Free Cash Flow 718.5 828.75 327.12 239.75
Free Cash Flow Growth -13.3 153.34 36.44 138.51
Free Cash Flow Yield 0.504 1.41 0.66 -0.116
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NSISb Price Commentary

Write your thoughts about Novozymes A/S B
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email